| Heliyon | |
| Abbreviation: | Heliyon |
| Discipline: | Multidisciplinary |
| Publisher: | Cell Press |
| History: | 2015–present |
| Impact: | 3.4 |
| Impact-Year: | 2023 |
| Frequency: | Monthly |
| Openaccess: | Yes |
| License: | CC BY |
| Eissn: | 2405-8440 |
| Oclc: | 934910176 |
| Website: | https://www.cell.com/heliyon/home |
| Link2: | https://www.sciencedirect.com/journal/heliyon/issues |
| Link2-Name: | Online archive |
Heliyon is a monthly peer-reviewed open-access mega journal covering research in science, medicine and engineering. Unlike most of its competitors, the journal will consider for publication works reporting negative/null results, incremental advances, and replication studies,[1] thus filling the market niche, which became vacant after the discontinuation of the Journal of Negative Results in Biomedicine in 2017.
Heliyon was established in 2015 by Cell Press, a division of Elsevier. According to the publisher's website: "the [journal's] name is all about shining light on important research. Helios was the Greek god of the sun. This root word gave us inspiration, as we want this journal to illuminate knowledge across a broad spectrum."[2]
The journal is divided into numerous sections, each with its own editorial team. Articles are published under a CC BY open access license.
The journal is abstracted and indexed in:
, the journal's indexation in the Science Citation Index Expanded is "on hold" and pending re-evaluation, with Web of Science citing the concerns on "the quality of the content published in this journal" as a reason for the suspension.[3]